期刊论文

【摘要】

Gastrointestinal (GI) cancer is the most common cancer in the world and one of the main causes of cancer-related death. Clinically, surgical excision and chemotherapy are the main treatment methods for GI cancer, which is unfortunately accompanied with serious adverse reactions and drug toxicity, bringing irreversible damage to patients and seriously affecting the quality of life. Ganoderma lucidum (G. lucidum) has a long history of medicinal and edible use in China. Its bioactive compounds mainly include polysaccharides, triterpenes, and proteins, which have potential anti-tumor activities by inhibiting proliferation, inducing apoptosis, inhibiting metastasis, and regulating autophagy. Currently, there is no in-depth review on the anti-tumor effect of G. lucidum in GI cancer. Therefore, this review is an attempt to compile the basic characteristics, anti-GI caner mechanisms, and clinical application of G. lucidum, aiming to provide a reference for further research on the role of G. lucidum in the prevention and treatment of GI cancer from the perspective of traditional Chinese and western medicine.Graphical Abstract

【授权许可】

CC BY
© International Society for Chinese Medicine and BioMed Central Ltd. 2023

【预览】

附件列表
Files	Size	Format	View
RO202309153879676ZK.pdf	2321KB	PDF	download
Fig. 3	348KB	Image	download
Fig. 5	1331KB	Image	download
Fig. 4	2819KB	Image	download
Fig. 2	319KB	Image	download

【图表】

Fig. 2

Fig. 4

Fig. 5

Fig. 3

【参考文献】

[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[39]
[40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[51]
[52]
[53]
[54]
[55]
[56]
[57]
[58]
[59]
[60]
[61]
[62]
[63]
[64]
[65]
[66]
[67]
[68]
[69]
[70]
[71]
[72]
[73]
[74]
[75]
[76]
[77]
[78]
[79]
[80]
[81]
[82]
[83]
[84]
[85]
[86]
[87]
[88]
[89]
[90]
[91]
[92]
[93]
[94]
[95]
[96]
[97]
[98]
[99]
[100]
[101]
[102]
[103]
[104]
[105]
[106]
[107]
[108]
[109]
[110]
[111]
[112]
[113]
[114]
[115]
[116]
[117]
[118]
[119]
[120]
[121]
[122]
[123]
[124]
[125]
[126]
[127]
[128]
[129]
[130]
[131]
[132]
[133]
[134]
[135]
[136]
[137]
[138]
[139]
[140]
[141]
[142]
[143]
[144]
[145]
[146]
[147]
[148]
[149]
[150]
[151]
[152]
[153]

Chinese Medicine
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Review
Bin Liu¹ Xiaoying Jiang² Ting Ye³ Yang Ge³ Hang Song⁴ Can Peng⁵
[1] Cancer Research Centre, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, 101149, Beijing, China;Department of Technology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, 101149, Beijing, China;School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, 230012, Hefei, China;School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, 230012, Hefei, China;Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, 233030, Bengbu, China;School of Pharmacy, Anhui University of Chinese Medicine, 230012, Hefei, China;
关键词: G. lucidum; GI cancer; Ganoderic acid; Molecular mechanism; Clinical application;
DOI : 10.1186/s13020-023-00811-y
received in 2023-05-05, accepted in 2023-07-22, 发布年份 2023
来源: Springer
PDF


	文献评价指标
	下载次数：8次	浏览次数：0次

【 摘 要 】

【 授权许可】

【 预 览 】

【 图 表 】

【 参考文献 】

【摘要】

【授权许可】

【预览】

【图表】

【参考文献】